Navigation Links
US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
Date:8/19/2010

are proud of the team effort within the US Oncology Research network that has allowed independent community-based physicians to participate in the development of new treatments for cancer."

"There are so many lives lost to cancer," said Dr. Kolibaba. "US Oncology Research and its physician participants understand that research leads to cancer cures, that new therapies extend survival, and that carefully conducted clinical trials are the only way that progress is achieved. There is no better way to help patients than to offer new treatments. Through participation in clinical trials, physicians can do both, treating cancer patients with the best possible care and moving the field forward."

US Oncology Research is physician-led and physician-driven with a successful history of clinical depth and expertise.  

  • More than 43,000 patients have participated in US Oncology Research trials.  
  • With the approval of Tasigna, US Oncology Research has played a role in the development of 42 cancer therapies approved by the FDA in less than two decades.
  • The US Oncology Research network includes more than 80 practices in 200 locations across the U.S.
  • The network supports 14 sites that offer Phase I trials, including first-in-human trials.
  • At any given time, the network has more than 200 active trials.
  • Leadership at US Oncology Research consists of experts in a wide variety of cancer specialties including Breast Cancer, Developmental Therapeutics, Gastrointestinal Cancer, Hematologic Cancer, Gynecologic Cancer, Genitourinary Cancer, Lung Cancer, Translational Oncology Program, and Radiation Therapy.
  • 57 manuscripts from investigator-initiated studies have been published in peer-reviewed journals.
  • US Oncology Research supports the nation's largest research network specializing in Phase I-IV oncology clinical trials.  Investigator- and sponsor-initiated
    '/>"/>

SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
2. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
3. US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
4. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
5. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
6. First Coast Oncology to Offer Next Generation Proton Therapy
7. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
8. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
9. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
10. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
11. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Greifensee, Switzerland (PRWEB) October 01, 2014 ... influence the quality of the final product. However, ... most regulated, regulatory frameworks such as Good Manufacturing ... is the responsibility of the manufacturer to interpret ... ensure consistent weighing performance quality. METTLER TOLEDO experts ...
(Date:10/1/2014)... Today the National Institutes of ... for the Brain Research through Advancing Innovative Neurotechnologies ... and revolutionize new methods of understanding the complexities ... This first round of grants totaling $46 million ... to more than 100 investigators in 15 states ...
(Date:10/1/2014)... Francisco, California (PRWEB) October 01, 2014 ... from the National Science Foundation to expand their bioCAD/CAM ... to build and modify DNA. The Small Business Innovation ... commercialize the “j5” technology under exclusive license from the ... Joint BioEnergy Institute , an LBNL laboratory that ...
(Date:9/30/2014)... a well-known optical phenomenon called thin-film interference, a ... the ability to "paint" ultra-thin coatings onto a ... making future, flexible electronic devices, creating advanced solar ... ships and spacecraft with extremely lightweight decorative logos. ... it becomes iridescent, revealing a myriad of colors ...
Breaking Biology Technology:Comply with Weighing-Related Regulations in Pharma Manufacturing 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Taking thin films to the extreme 2
... Expands Decision Resources, Inc.,s Portfolio to Include Global ... Physician and Consumer Digital Market Research, ... Inc., one of the world,s leading research and advisory ... it,acquired Manhattan Research, a leading provider of access to ...
... AVIV, Israel, June 17 BSP Ltd.,( http://www.bsp.co.il/pressall.asp ... for non-invasive diagnosis and monitoring of Ischemic Heart,Disease, ... a private,funding round, that included existing shareholders in ... developed the HyperQ(TM), a cutting-edge technology that offers,highly ...
... and fast PCR amplification ... in a fully portable ... a leading,developer of state-of-the-art PCR devices and Cell-based assay systems,today ... San,Diego Convention Center that it has successfully completed development of,Palm ...
Cached Biology Technology:Decision Resources, Inc. Acquires Manhattan Research 2Decision Resources, Inc. Acquires Manhattan Research 3BSP Raises $2.6 Million Dollars From Private Investors 2Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device 2
(Date:9/30/2014)... . FRANKFURT. Truffles, ... the world. Because they grow underground, people use trained dogs ... truffles is not only of interest to gourmets. A group ... Goethe University Frankfurt have discovered that the smell of white ... inside truffle fruiting bodies. , White truffles from the Piedmont ...
(Date:9/30/2014)... that a new class of chemical compounds makes ... have also pinpointed the relevant target enzyme, thus ... , Researchers led by LMU,s Professor Angelika Vollmar ... Mnchen have identified a class of chemicals that ... against malignant tumors. The compound is itself non-toxic, ...
(Date:9/30/2014)... available in German . ... response to risky situations such as exposure to predators. ... found in a long-term study on different populations of ... rate and ambient temperature. High metabolic rates and low ... these scenarios birds were more likely to approach potential ...
Breaking Biology News(10 mins):On the trail of the truffle flavor 2Cancer therapy: Driving cancer cells to suicide 2Risky metabolism 2
... As the 2010 United Nations International Year of ... (MBG) and the Royal Botanic Gardens, Kew (RBG Kew) ... international resource is a working list of all land ... diversity and effective conservation of plants. The completion of ...
... In a recent issue of HortTechnology , Purdue ... on a study of the effects of a technique called ... are commonly applied as sprays or media drenches, bulb crops ... The experiments were designed to determine if dipping Easter lily ...
... Dec. 29, 2010 Patients with diabetes, kidney disease and ... have a higher risk of cardiovascular disease or death, researchers ... results suggest that testing such patients, responsiveness to the drug ... their risk, said Dr. Robert Toto, professor of internal medicine ...
Cached Biology News:Kew Gardens and Missouri Botanical Garden announce the completion of the Plant List 2Kew Gardens and Missouri Botanical Garden announce the completion of the Plant List 3Bulb dipping controls Easter lily growth 2Poor response to anti-anemia drug predicts higher risk of heart disease or death 2Poor response to anti-anemia drug predicts higher risk of heart disease or death 3
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
PPIF Antibody...
Rabbit polyclonal to FLIP ( Abpromise for all tested applications). entrezGeneID: 8837 SwissProtID: O15519...
Fluorescein isothiocyanate (FITC) mouse anti-human IFN-alpha2 50 ug...
Biology Products: